State-of-the-art-of-the-Pharmaceutical-Industry
State of the art of the Pharmaceutical Industry
In the United States alone, more than $100 billion is spent annually on pharmaceutical research and development. The pharmaceutical industry has a higher level of expenditures than any other manufacturing sector in the nation’s economy. Advances in technology and long...
Tags: drug discovery, pharmaceutical industry, drugs, drug development, clinical trials...
June 5, 2014
AstraZeneca-and-Pfizer-merger-Do-cancer-patients-loose
AstraZeneca and Pfizer merger: Do cancer patients loose?
Even the most-sold drug of Pfizer was an aquisition. therefore, expert predict that the company can only survive if it merges with others. ...
Tags: pfizer, astrazeneca, pfizer merge, astra zeneca aquisition...
May 1, 2014
Novartis-has-announced-the-results-of-phase-4-INSTEAD-study
Novartis has announced the results of phase 4 INSTEAD study
Novartis has announced the result of a Phase 4 INSTEAD research made to imporve its new COPD drug. Once-daily indacaterol has shown very promising data....
Tags: durg development, INSTEAD Swift study, GSK, Novartis, pharmaceutical news, pharmaceutical companies...
April 29, 2014
Novartis-experiences-a-solid-growth
Novartis experiences a solid growth
Perhaps as the result of definitive agreements with GSK and Eli Lilly, Novartis announced that it has produced a solid growth in the subsequent quarter's end. ...
Tags: Novartis, sotck growth, pharmaceutical growth, novartis stocks...
April 29, 2014
What-is-happening-with-AstraZeneca
What is happening with AstraZeneca.
Pfizer announced to buy AstraZeneca many times. But what is in the backround of this diecision and what is happening with the two companies?...
Tags: Astra Zeneca, Pfizer, pharmaceutical companies, astraZeneca business....
April 29, 2014
Novartis-contributes-with-GSK-and-changes-protfolio
Novartis contributes with GSK and changes protfolio
Novartis announced that it is going to transform its portfolio and strenghtens its researches by acquiring products of GSK's oncology wing. ...
Tags: GSK, Novartis, pharmaceutical companies, pharmaceutical news, drug discovery, oncology srugs...
April 24, 2014
Agenus-and-Merck-collaborate-on-research-towards-immune-checkpoints
Agenus and Merck collaborate on research towards immune checkpoints
Agenus, an immuno-oncology company is going to contribute with Merck on developing therapeutic antibodies for immune checkpoints. This technique will open a new chapter in the field of cancer research too. ...
Tags: cancer, immune checkpoint, cancer research...
May 1, 2014
Neumedicines-ha-a-new-Phase-I-study
Neumedicines ha a new Phase I study
Neumedicines announced that their proposal to conduct a Phase I clinical study of recombinant human interleukin-12 (rHuIL-12) for the treatment of traumatic wounds has been recommended for funding subject to negotiations by the Department of Defense (DOD) office of the ...
Tags: Neumedicines, phase I study, phase I clinical trial, drugresearch, drug discovery...
May 1, 2014
AstraZeneca-suffers-17-fall-but-still-stands
AstraZeneca suffers 17% fall, but still stands
Astra zeneca suffered 17% loss on stock exchange due to patent loosings of veteran drugs. However, the company is still positive about its future and hopes to regain what it has lost....
Tags: pharma, pharmaceutical companies, pharma loss, Astra Zeneca, veteran drugs...
April 29, 2014
The-price-of-AstraZeneca-s-stock-increased-after-Pfizers-offer
The price of AstraZeneca 's stock increased after Pfizer's offer
The price of AstraZeneca stocks runned up after Pfizer announced that it is willing to buy o buy the company for around $100 billion. Lately, AstraZeneca turned down another similar offer. ...
Tags: Stock, pharmaceutival business, pharmaceutical companies, AstraZeneca, Pfizer, pharmaceutical stock exchange, pharma stocks, astrazeneca sold...
April 29, 2014
New-Drug-Applications-of-Gilead-was-Accepted-by-FDA
New Drug Applications of Gilead was Accepted by FDA
Gilead has announced that its new drug application was accepted by FDA. The new drug is going to be a novel HIV treatment. ...
Tags: drug, drug development, FDA, HIV drug, Gilead, aids drug...
April 24, 2014
GlaxoSmithKline-and-Novartis-sigent-a-three-part-agreemnet
GlaxoSmithKline and Novartis sigent a three-part agreemnet
GSK will accquire vaccines of Novartis. This is only one point of the three-part agreement which was signed by the two pharmaceutical giants. Both companies hope development....
Tags: novartis, GKS, vaccination business, pharmaceutical business, pharmaceutical news, pharmaceutical business news. ...
April 24, 2014
MOST VIEWED
«« Prev 1 2 3 4 5 Next »» Last

HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013